general
- Generic Name : Abacavir Sulfate and Lamivudine
- Pronunciation : a-BAK-a-vir SUL-fate/la-MIV-ue-deen
- ICD Code : Y41.5
- Therapeutic Classification : Antiretroviral Agents
prescription
- Abacavir Sulfate and Lamivudine form a fixed-dose combination of antiviral medications utilized in the treatment of AIDS/HIV infection, specifically in children.
- These drugs function to inhibit or decelerate damage to the immune system, thereby reducing the risk of developing AIDS.
risk factors
- Hypersensitivity
side effects
- Common : Hypersensitivity, sleeplessness, depression, headache, migraine, fatigue, uneasiness, dizziness, nausea, vomiting, diarrhea, rash, fever, abdominal pain, abnormal dreams, anxiety, cough or Inflammation of the pharynx, eye problems, enlarged lymph nodes and swollen ankles
- Body : Redistribution/accumulation of body fat
- Gastrointestinal : Mouth ulcer, sore throat
- Metabolic : Blood sugar
- General : Weakness
- Blood : Anemia
- Hypersensitivity : Hives
- Musculoskeletal : Muscle weakness, CPK elevation, damaged skeletal muscle
- Central Nervous System : Tingling, nerve disease, seizures
- Respiratory : Abnormal breath sounds/wheezing
- Skin : Hair loss, redness, Stevens-Johnson syndrome
dosage
- 1 tablet Daily
how to take
- Oral with or without food – 600 mg (as sulfate)/lamivudine 300 mg)
warning
- Exercise caution in patients with a history of liver or kidney impairment, heart disease, diabetes, cholesterol issues, poor immunity, those taking other medications, individuals with allergies, the elderly, children, as well as during pregnancy and breastfeeding.
- It’s important to note that this medication does not prevent the spread of infections to others. Consequently, it is advised to abstain from sexual contact during the treatment period.
storage
Room Temperature (25°C)